|
|
|
15/10/2007
Orexo förvärvar Biolipox - ett innovativt specialty pharmabolag skapas.
Read more »
15/10/2007
Aerocrine ingår samarbete för bättre behandling av astma och tarmsjukdomar.
Read more »
25/09/2007
Biolipox Signs Asset Purchase Agreement with Inflazyme Pharmaceuticals
Read more »
19/09/2007
AdvanDx Launches the First LNA-Based In Vitro Diagnostic Test for Detection of
Antibiotic Resistant “Superbugs”.
Read more »
18/09/2007
AdvanDx Closes $15 million Series C Financing Round from bioMérieux,
LD Pensions and SLS Venture.
Read more »
05/09/2007
Per Carendi ny CEO på SLS Venture
Read more »
05/09/2007
Per Carendi new CEO of SLS Venture
Read more »
05/09/2007
Per Carendi ny VD på SLS Venture
Read more »
10/07/2007
LSO FINAL B Round 7-10-07.
Read more »
29/06/2007
OxThera - Raises SEK 150 Million in New Round of Financing.
Read more »
11/06/2007
Aerocrine noteras på Stockholmsbörsen.
Read more »
31/05/2007
Aerocrine AB - Vinnare av årets SwedenBIO Award.
Read more »
31/05/2007
Exiqon - Full exercise of overallotment option.
Read more »
25/05/2007
Exiqon - IPO now priced. Oversubscription 7 times.
Read more »
22/05/2007
AdvanDx and bioMérieux Partner to Provide Rapid Results for Bloodstream Infections.
Read more »
15/05/2007
Nyemission i Aerocrine.
Read more »
14/05/2007
Exiqon A/S published a prospectus.
Read more »
02/05/2007
Exiqon A/S is considering a potential IPO on the Copenhagen Stock Exchange and elects Thorleif Krarup new Chairman.
Read more »
14/02/2007
Light Sciences Oncology Initiates Phase II Trial of Litx™ Therapy in Patients with Glioma.
Read more »
13/02/2007
Gyros completes five new sales of its Gyrolab® protein quantification platform.
Read more »
13/02/2007
Gyros introduces new product for high concentration protein quantification.
Read more »
08/01/2007
LIGHT SCIENCES ONCOLOGY RECEIVES SPECIAL PROTOCOL ASSESSMENT FOR PIVOTAL PHASE III TRIAL OF LITX™ THERAPY IN METASTATIC COLORECTAL CANCER
Read more »
08/01/2007
Biolipox asthma project moves closer to clinical development.
Read more »
04/01/2007
LIGHT SCIENCES ONCOLOGY PURCHASES THE ASSETS OF ITS FORMER PARENT COMPANY LIGHT SCIENCES LLC IN EQUITY TRANSACTION.
Read more »
|